Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort

BACKGROUND/AIMS: Vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is one of the best policies to control COVID-19 pandemic. The serological response to COVID-19 vaccination in Taiwanese patients with different comorbidities is elusive. METHODS: Uninfected subjects who...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chung-Feng, Jang, Tyng-Yuan, Wu, Ping-Hsun, Kuo, Mei-Chuan, Yeh, Ming-Lun, Wang, Chih-Wen, Liang, Po-Cheng, Wei, Yu-Ju, Hsu, Po-Yao, Huang, Ching-I, Hsieh, Ming-Yen, Lin, Yi-Hung, Hsiao, Hui-Hua, Hsu, Chin-Mu, Huang, Chien-Tzu, Lee, Chun-Yuan, Chen, Yen-Hsu, Chen, Tun-Chieh, Lin, Kun-Der, Wang, Shuo-Hung, Wang, Sheng-Fan, Huang, Jee-Fu, Dai, Chia-Yen, Chuang, Wan-Long, Yu, Ming-Lung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237078/
https://www.ncbi.nlm.nih.gov/pubmed/37268999
http://dx.doi.org/10.1186/s12985-023-02056-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237078/
https://www.ncbi.nlm.nih.gov/pubmed/37268999
http://dx.doi.org/10.1186/s12985-023-02056-5

Ejemplares similares